Medical Device Investing ChroMedX Reports on HemoPalm Techno-Commercial Analysis and Productization Plan
Medical Device Investing ChroMedX Appoints Michaela Shaw as Director of Quality Assurance and Regulatory Assurance
Medical Device Investing ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
Medical Device Investing ChroMedX Accelerates Software Development and Implementation Activities; Appoints iGAL Roytblat, Formerly of Kangaroo Group, as CTO, Amid Expansion
Medical Device Investing ChroMedX Appoints Raj Kailasanathan as Executive Vice President Corporate Finance
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
